Medical - Equipment & Services
Compare Stocks
5 / 10Stock Comparison
NVST vs MMSI vs ITGR vs HSIC vs SYK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
Medical - Devices
Medical - Distribution
Medical - Devices
NVST vs MMSI vs ITGR vs HSIC vs SYK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Equipment & Services | Medical - Instruments & Supplies | Medical - Devices | Medical - Distribution | Medical - Devices |
| Market Cap | $3.95B | $3.65B | $3.03B | $8.13B | $109.33B |
| Revenue (TTM) | $2.81B | $1.54B | $1.85B | $13.18B | $25.12B |
| Net Income (TTM) | $68M | $139M | $142M | $398M | $3.25B |
| Gross Margin | 55.1% | 48.7% | 23.3% | 29.1% | 63.5% |
| Operating Margin | 9.0% | 12.2% | 10.4% | 5.8% | 22.4% |
| Forward P/E | 17.0x | 15.1x | 14.4x | 13.2x | 19.1x |
| Total Debt | $1.71B | $898M | $1.40B | $3.69B | $14.86B |
| Cash & Equiv. | $1.21B | $449M | $17M | $156M | $4.01B |
NVST vs MMSI vs ITGR vs HSIC vs SYK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Envista Holdings Co… (NVST) | 100 | 114.7 | +14.7% |
| Merit Medical Syste… (MMSI) | 100 | 136.2 | +36.2% |
| Integer Holdings Co… (ITGR) | 100 | 111.3 | +11.3% |
| Henry Schein, Inc. (HSIC) | 100 | 116.6 | +16.6% |
| Stryker Corporation (SYK) | 100 | 145.8 | +45.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NVST vs MMSI vs ITGR vs HSIC vs SYK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NVST is the #2 pick in this set and the best alternative if momentum is your priority.
- +36.4% vs MMSI's -36.2%
MMSI ranks third and is worth considering specifically for long-term compounding and sleep-well-at-night.
- 209.3% 10Y total return vs SYK's 179.2%
- Lower volatility, beta 0.66, Low D/E 56.7%, current ratio 4.34x
- Beta 0.66, current ratio 4.34x
- 11.7% revenue growth vs HSIC's 4.0%
Among these 5 stocks, ITGR doesn't own a clear edge in any measured category.
HSIC is the clearest fit if your priority is value.
- Lower P/E (13.2x vs 14.4x)
SYK carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 34 yrs, beta 0.52, yield 1.2%
- Rev growth 11.2%, EPS growth 8.2%, 3Y rev CAGR 10.8%
- PEG 1.28 vs NVST's 11.37
- 12.9% margin vs NVST's 2.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.7% revenue growth vs HSIC's 4.0% | |
| Value | Lower P/E (13.2x vs 14.4x) | |
| Quality / Margins | 12.9% margin vs NVST's 2.4% | |
| Stability / Safety | Beta 0.52 vs NVST's 1.63 | |
| Dividends | 1.2% yield; 34-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +36.4% vs MMSI's -36.2% | |
| Efficiency (ROA) | 6.9% ROA vs NVST's 1.2%, ROIC 11.4% vs 4.8% |
NVST vs MMSI vs ITGR vs HSIC vs SYK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NVST vs MMSI vs ITGR vs HSIC vs SYK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SYK leads in 3 of 6 categories
HSIC leads 1 • ITGR leads 1 • NVST leads 0 • MMSI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SYK leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SYK is the larger business by revenue, generating $25.1B annually — 16.3x MMSI's $1.5B. SYK is the more profitable business, keeping 12.9% of every revenue dollar as net income compared to NVST's 2.4%. On growth, NVST holds the edge at +14.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.8B | $1.5B | $1.8B | $13.2B | $25.1B |
| EBITDAEarnings before interest/tax | $342M | $290M | $328M | $1.1B | $6.3B |
| Net IncomeAfter-tax profit | $68M | $139M | $142M | $398M | $3.2B |
| Free Cash FlowCash after capex | $220M | $274M | $168M | $561M | $4.3B |
| Gross MarginGross profit ÷ Revenue | +55.1% | +48.7% | +23.3% | +29.1% | +63.5% |
| Operating MarginEBIT ÷ Revenue | +9.0% | +12.2% | +10.4% | +5.8% | +22.4% |
| Net MarginNet income ÷ Revenue | +2.4% | +9.0% | +7.7% | +3.0% | +12.9% |
| FCF MarginFCF ÷ Revenue | +7.8% | +17.8% | +9.1% | +4.3% | +17.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +14.4% | +7.8% | +0.8% | +7.7% | +11.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +130.0% | +38.8% | +172.7% | +14.9% | +56.0% |
Valuation Metrics
HSIC leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 21.7x trailing earnings, HSIC trades at a 75% valuation discount to NVST's 86.6x P/E. Adjusting for growth (PEG ratio), SYK offers better value at 2.29x vs NVST's 57.98x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.0B | $3.7B | $3.0B | $8.1B | $109.3B |
| Enterprise ValueMkt cap + debt − cash | $4.4B | $4.1B | $4.4B | $11.7B | $120.2B |
| Trailing P/EPrice ÷ TTM EPS | 86.57x | 28.77x | 30.49x | 21.66x | 33.98x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.97x | 15.05x | 14.39x | 13.25x | 19.06x |
| PEG RatioP/E ÷ EPS growth rate | 57.98x | — | 6.93x | 6.87x | 2.29x |
| EV / EBITDAEnterprise value multiple | 13.01x | 12.87x | 13.17x | 10.90x | 19.76x |
| Price / SalesMarket cap ÷ Revenue | 1.45x | 2.41x | 1.64x | 0.62x | 4.35x |
| Price / BookPrice ÷ Book value/share | 1.32x | 2.34x | 1.80x | 1.80x | 4.87x |
| Price / FCFMarket cap ÷ FCF | 17.15x | 16.95x | 28.84x | 14.18x | 25.53x |
Profitability & Efficiency
SYK leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
SYK delivers a 15.0% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $2 for NVST. NVST carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to ITGR's 0.80x. On the Piotroski fundamental quality scale (0–9), NVST scores 7/9 vs HSIC's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.2% | +8.9% | +8.2% | +8.2% | +15.0% |
| ROA (TTM)Return on assets | +1.2% | +5.2% | +4.2% | +3.6% | +6.9% |
| ROICReturn on invested capital | +4.8% | +7.2% | +5.4% | +7.1% | +11.4% |
| ROCEReturn on capital employed | +4.9% | +7.9% | +6.9% | +9.8% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 5 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.55x | 0.57x | 0.80x | 0.77x | 0.66x |
| Net DebtTotal debt minus cash | $496M | $450M | $1.4B | $3.5B | $10.8B |
| Cash & Equiv.Liquid assets | $1.2B | $449M | $17M | $156M | $4.0B |
| Total DebtShort + long-term debt | $1.7B | $898M | $1.4B | $3.7B | $14.9B |
| Interest CoverageEBIT ÷ Interest expense | 12.76x | 10.74x | 5.07x | 4.59x | 6.72x |
Total Returns (Dividends Reinvested)
ITGR leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SYK five years ago would be worth $11,752 today (with dividends reinvested), compared to $5,353 for NVST. Over the past 12 months, NVST leads with a +36.4% total return vs MMSI's -36.2%. The 3-year compound annual growth rate (CAGR) favors ITGR at 2.9% vs NVST's -11.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +11.8% | -29.1% | +14.8% | -7.8% | -17.8% |
| 1-Year ReturnPast 12 months | +36.4% | -36.2% | -26.3% | +2.8% | -24.5% |
| 3-Year ReturnCumulative with dividends | -30.4% | -27.8% | +9.1% | -11.3% | +2.4% |
| 5-Year ReturnCumulative with dividends | -46.5% | -2.7% | -4.2% | -14.6% | +17.5% |
| 10-Year ReturnCumulative with dividends | -13.3% | +209.3% | +165.7% | +5.8% | +179.2% |
| CAGR (3Y)Annualised 3-year return | -11.4% | -10.3% | +2.9% | -3.9% | +0.8% |
Risk & Volatility
Evenly matched — NVST and SYK each lead in 1 of 2 comparable metrics.
Risk & Volatility
SYK is the less volatile stock with a 0.52 beta — it tends to amplify market swings less than NVST's 1.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVST currently trades 79.7% from its 52-week high vs MMSI's 61.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.63x | 0.66x | 0.71x | 0.72x | 0.52x |
| 52-Week HighHighest price in past year | $30.42 | $100.19 | $123.78 | $89.29 | $404.87 |
| 52-Week LowLowest price in past year | $16.41 | $59.74 | $62.00 | $61.95 | $284.97 |
| % of 52W HighCurrent price vs 52-week peak | +79.7% | +61.2% | +71.2% | +79.3% | +70.5% |
| RSI (14)Momentum oscillator 0–100 | 36.4 | 37.3 | 54.7 | 34.3 | 26.6 |
| Avg Volume (50D)Average daily shares traded | 2.5M | 758K | 621K | 1.2M | 2.1M |
Analyst Outlook
SYK leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NVST as "Hold", MMSI as "Buy", ITGR as "Buy", HSIC as "Hold", SYK as "Buy". Consensus price targets imply 55.1% upside for MMSI (target: $95) vs 11.2% for ITGR (target: $98). SYK is the only dividend payer here at 1.18% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $27.44 | $95.00 | $98.00 | $85.43 | $389.62 |
| # AnalystsCovering analysts | 19 | 14 | 14 | 32 | 50 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +1.2% |
| Dividend StreakConsecutive years of raises | — | — | — | 1 | 34 |
| Dividend / ShareAnnual DPS | — | — | — | — | $3.36 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.2% | 0.0% | +1.6% | +10.5% | 0.0% |
SYK leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HSIC leads in 1 (Valuation Metrics). 1 tied.
NVST vs MMSI vs ITGR vs HSIC vs SYK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NVST or MMSI or ITGR or HSIC or SYK a better buy right now?
For growth investors, Merit Medical Systems, Inc.
(MMSI) is the stronger pick with 11. 7% revenue growth year-over-year, versus 4. 0% for Henry Schein, Inc. (HSIC). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 7x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Merit Medical Systems, Inc. (MMSI) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NVST or MMSI or ITGR or HSIC or SYK?
On trailing P/E, Henry Schein, Inc.
(HSIC) is the cheapest at 21. 7x versus Envista Holdings Corp at 86. 6x. On forward P/E, Henry Schein, Inc. is actually cheaper at 13. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Stryker Corporation wins at 1. 28x versus Envista Holdings Corp's 11. 37x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — NVST or MMSI or ITGR or HSIC or SYK?
Over the past 5 years, Stryker Corporation (SYK) delivered a total return of +17.
5%, compared to -46. 5% for Envista Holdings Corp (NVST). Over 10 years, the gap is even starker: MMSI returned +209. 3% versus NVST's -13. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NVST or MMSI or ITGR or HSIC or SYK?
By beta (market sensitivity over 5 years), Stryker Corporation (SYK) is the lower-risk stock at 0.
52β versus Envista Holdings Corp's 1. 63β — meaning NVST is approximately 213% more volatile than SYK relative to the S&P 500. On balance sheet safety, Envista Holdings Corp (NVST) carries a lower debt/equity ratio of 55% versus 80% for Integer Holdings Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — NVST or MMSI or ITGR or HSIC or SYK?
By revenue growth (latest reported year), Merit Medical Systems, Inc.
(MMSI) is pulling ahead at 11. 7% versus 4. 0% for Henry Schein, Inc. (HSIC). On earnings-per-share growth, the picture is similar: Envista Holdings Corp grew EPS 104. 3% year-over-year, compared to -15. 0% for Integer Holdings Corporation. Over a 3-year CAGR, ITGR leads at 11. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NVST or MMSI or ITGR or HSIC or SYK?
Stryker Corporation (SYK) is the more profitable company, earning 12.
9% net margin versus 1. 7% for Envista Holdings Corp — meaning it keeps 12. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SYK leads at 19. 5% versus 5. 7% for HSIC. At the gross margin level — before operating expenses — SYK leads at 64. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NVST or MMSI or ITGR or HSIC or SYK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Stryker Corporation (SYK) is the more undervalued stock at a PEG of 1. 28x versus Envista Holdings Corp's 11. 37x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Henry Schein, Inc. (HSIC) trades at 13. 2x forward P/E versus 19. 1x for Stryker Corporation — 5. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMSI: 55. 1% to $95. 00.
08Which pays a better dividend — NVST or MMSI or ITGR or HSIC or SYK?
In this comparison, SYK (1.
2% yield) pays a dividend. NVST, MMSI, ITGR, HSIC do not pay a meaningful dividend and should not be held primarily for income.
09Is NVST or MMSI or ITGR or HSIC or SYK better for a retirement portfolio?
For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
52), 1. 2% yield, +179. 2% 10Y return). Envista Holdings Corp (NVST) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SYK: +179. 2%, NVST: -13. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NVST and MMSI and ITGR and HSIC and SYK?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
SYK pays a dividend while NVST, MMSI, ITGR, HSIC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.